FindTrial
Sign In

Efficacy of a single intravenous venous dose of Parecoxib 40 mg for post-operative pain control after elective cesarean delivery: a double blind randomized controlled trial

Efficacy of a single intravenous venous dose of Parecoxib 40 mg for post-operative pain control after elective cesarean delivery: a double blind randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20140618001
Enrollment
Unknown
Registered
2014-06-18
Start date
2014-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy previous cesarean delivery Parecoxib postoperative pain previous cesarean delivery

Interventions

0.9% NSS 2 mL,a single dose 40 mg (2 mL) Parecoxib
Placebo Comparator Drug,Experimental Drug
Control,Experiment

Sponsors

Siriraj Routine to Research Unit
Lead Sponsor
Siriraj Routine to Research Unit
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1 Term pregnancy aged over 20 years old 2 Previous cesarean delivery 3 Elective cesarean delivery 4 Analgesia planning is spinal block 5 Able to read and write Thai language

Exclusion criteria

Exclusion criteria: 1. Allergy to NSAIDs 2. Contraindication to NSAIDs use 3. Warfarin or azole drugs use

Design outcomes

Primary

MeasureTime frame
Morphine and its derivatives 24 hours after cesarean delivery total doses of morphine and its derivatives—

Secondary

MeasureTime frame
Pain 24 hours after cesarean delivery Pain score,Breast milk 24 hours after cesarean delivery Time interval after surgery to production of breast milk,Cost 24 hours after cesarean delivery total cost of analgesia for pain control—

Countries

Thailand

Contacts

Public ContactTripop Lertbunnaphong

Faculty of Medicine. Siriraj Hospital. Mahidol University

tripop2520@hotmail.com+66818749282

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026